OBaris at BIO International Convention 2024
OBaris was part of the SWISS BIOTECH Pavilion at BIO International Convention 2024, the world’s largest global partnering eve
OBaris is selected for the Venture Leaders Biotech 2024!
OBaris is excited to share that we joined the Swiss National Startup Team! Represented by our CEO David Klein Cerrejon, we wi
OBaris wins Venture Kick Stage III
OBaris wins Stage III Venture Kick and receives additional CHF 100’000! Read the announcement and learn more about our Ventur
OBaris receives support from Gebert Rüf Foundation
OBaris receives CHF 150’000 for the accelerated market entry from Gebert Rüf Foundation! As a part of their InnoBooster progr
OBaris at Swiss Nordic Bio 2024
Our co-founder David Klein Cerrejon pitched at Swiss Nordic Bio 2024 in the biotech section! David and Nevena had exciting di
Transire Bio receives Bridge Proof of Concept Fellowship
Transire Bio represented by our co-founder David Klein Cerrejon, receives the Bridge Proof of Concept Fellowship! The BRIDGE
OBaris is selected for the Venture Leaders Biotech 2024!
OBaris is excited to share that we joined the Swiss National Startup Team! Represented by our CEO Da
OBaris wins Venture Kick Stage III
OBaris wins Stage III Venture Kick and receives additional CHF 100’000! Read the announcement and le
OBaris receives support from Gebert Rüf Foundation
OBaris receives CHF 150’000 for the accelerated market entry from Gebert Rüf Foundation! As a part o
OBaris at Swiss Nordic Bio 2024
Our co-founder David Klein Cerrejon pitched at Swiss Nordic Bio 2024 in the biotech section! David a
Transire Bio receives Bridge Proof of Concept Fellowship
Transire Bio represented by our co-founder David Klein Cerrejon, receives the Bridge Proof of Concep
Transire Bio in ftmedien
Story about Transire Bio featured in ftmedien! Read the complete article at Saugnäpfe statt Nadelsti
Transire Bio wins the Venture Kick Stage II
Transire Bio receives additional CHF 40’000 and advances to the next stage of Venture Kick! Venture